Cargando…

PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE

Detalles Bibliográficos
Autores principales: José Jiménez Nájar, Francisco, Olivares Pérez, Belén, Aguirre Lora, Alicia, Romero Mata, Noelia, García Torres, Estefanía, Martín Calvo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428844/
http://dx.doi.org/10.1097/01.HS9.0000976532.80344.a9
_version_ 1785090567526416384
author José Jiménez Nájar, Francisco
Olivares Pérez, Belén
Aguirre Lora, Alicia
Romero Mata, Noelia
García Torres, Estefanía
Martín Calvo, Carmen
author_facet José Jiménez Nájar, Francisco
Olivares Pérez, Belén
Aguirre Lora, Alicia
Romero Mata, Noelia
García Torres, Estefanía
Martín Calvo, Carmen
author_sort José Jiménez Nájar, Francisco
collection PubMed
description
format Online
Article
Text
id pubmed-10428844
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288442023-08-17 PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE José Jiménez Nájar, Francisco Olivares Pérez, Belén Aguirre Lora, Alicia Romero Mata, Noelia García Torres, Estefanía Martín Calvo, Carmen Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428844/ http://dx.doi.org/10.1097/01.HS9.0000976532.80344.a9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
José Jiménez Nájar, Francisco
Olivares Pérez, Belén
Aguirre Lora, Alicia
Romero Mata, Noelia
García Torres, Estefanía
Martín Calvo, Carmen
PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title_full PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title_fullStr PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title_full_unstemmed PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title_short PB2457: RUXOLITINIB AS TREATMENT IN PATIENTS WITH ACUTE AND CRONIC GRAFT-VERSUS-HOST DISEASE. REAL WORLD EVIDENCE
title_sort pb2457: ruxolitinib as treatment in patients with acute and cronic graft-versus-host disease. real world evidence
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428844/
http://dx.doi.org/10.1097/01.HS9.0000976532.80344.a9
work_keys_str_mv AT josejimeneznajarfrancisco pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence
AT olivaresperezbelen pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence
AT aguirreloraalicia pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence
AT romeromatanoelia pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence
AT garciatorresestefania pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence
AT martincalvocarmen pb2457ruxolitinibastreatmentinpatientswithacuteandcronicgraftversushostdiseaserealworldevidence